Medium & long-chain acylcarnitine’s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study

MLA

Chang Liu, et al. “Medium & Long-Chain Acylcarnitine’s Relation to Lipid Metabolism as Potential Predictors for Diabetic Cardiomyopathy: A Metabolomic Study.” Lipids in Health and Disease, vol. 20, no. 1, Nov. 2021, pp. 1–19. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....940f3c439e6b892b700a92d3f319c648&authtype=sso&custid=ns315887.

APA

Chang Liu, Xuejiao Xing, Xiao-Lei Shen, Ming-Hao Ge, Dong-zhuo Wei, Dan-meng Zheng, Ding-wen Jiang, & Zhen-ni An. (2021). Medium & long-chain acylcarnitine’s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study. Lipids in Health and Disease, 20(1), 1–19.

Chicago

Chang Liu, Xuejiao Xing, Xiao-Lei Shen, Ming-Hao Ge, Dong-zhuo Wei, Dan-meng Zheng, Ding-wen Jiang, and Zhen-ni An. 2021. “Medium & Long-Chain Acylcarnitine’s Relation to Lipid Metabolism as Potential Predictors for Diabetic Cardiomyopathy: A Metabolomic Study.” Lipids in Health and Disease 20 (1): 1–19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....940f3c439e6b892b700a92d3f319c648&authtype=sso&custid=ns315887.